Erlotinib might be a double‐edged sword in HCC

E-ISSN： 1527-3350|61|2|729-729

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.2, 2015-02, pp. : 729-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypothermia: A Double-Edged Sword

Cardiology, Vol. 122, Iss. 2, 2012-07 ,pp. : 126-128

Karger

Access to resources Recommend Favorite

JNK: A double‐edged sword in tumorigenesis

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1470-1472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory angiogenesis in atherogenesis—a double-edged sword

By Ribatti Domenico Levi-Schaffer Francesca Kovanen Petri

Annals of Medicine, Vol. 40, Iss. 8, 2008-12 ,pp. : 606-621

Informa Healthcare

Access to resources Recommend Favorite

Aging and Cancer: The Double‐Edged Sword of Replicative Senescence

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 45, Iss. 4, 1997-04 ,pp. : 482-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Inhibition of Telomerase in Human Cancer: Will It Be a Double-Edged Sword?

Oncology Research and Treatment, Vol. 24, Iss. 1, 2001-03 ,pp. : 22-26

Karger

Access to resources Recommend Favorite